![]() |
CAFTA
Quote:
Quote:
Is there some reason why you want U.S. businesses to have to compete on an unfair playing field? Are you just that hostile to the idea of protecting the environment, or workplace safety? |
CAFTA
Quote:
Considering such factors as part of the treaty-negotiating exercise delays the time at which American companies can move in and set up shop, and therefore is extraneous at best, and at worst fucks up a really good tarriff-elimination plan. The market will solve these problems, as long as it doesn't relate to SDI or stem cells. It's quite simple, really. |
Liberal hunt.
Quote:
Companies always take risks on possibly failing products, because there's a reward of selling something profitable. They take calculated, reasonable risks. The reason there's no private development of SDI is because the market is very limited. There's one customer (sorry, no US company is going to be allowed to sell to anyone else), and they'll probably drive a hard bargain. Given that's the situation, the government has to commit to making a purchase in advance, but funding the development and guaranteeing a purchase of some sort (or at least funding the costs, so that the company doesn't throw away the money). So it's not like disease research, other than in very limited circumstances (e.g., Orphan Drugs), where we do provide money to research cures for rare diseases, as market incentives (i.e., too small a market) would be insufficient to develop cures. |
CAFTA
Quote:
|
Way to go, Spanky.
Quote:
|
Liberal hunt.
Quote:
|
CAFTA
Quote:
|
Not necessarily backwards.
Quote:
There's actually a greater case for stem cell funding at this stge than there is for orphan drugs, because the potential market is zero and will be for decades. At this point, we don't even know that embryonic stem cells can be trained to develop in the needed way. Once that has been determined, the health care industry is still looking at extensive development to get to the testing stage. The reason to fund stem cell research is that it has the potential to one day cure diseases which are not currently curable, and to reverse conditions which are not currently reversible. The possibility is simply too great not to fund. |
CAFTA
Quote:
Quote:
|
Way to go, Spanky.
Quote:
|
Not necessarily backwards.
Quote:
|
Not necessarily backwards.
Quote:
|
Not necessarily backwards.
Quote:
Moreover, even within the medical research arena, the distribution of federal funding is influenced more by interest group politics than any rational calculus of risk and reward. I'm not sure how one can pick out stem cell research for some favored treatment just because it offers such promise. |
Not necessarily backwards.
Quote:
|
CAFTA
Quote:
Quote:
Quote:
|
All times are GMT -4. The time now is 04:18 PM. |
Powered by: vBulletin, Copyright ©2000 - 2008, Jelsoft Enterprises Limited.
Hosted By: URLJet.com